SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 42 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,667,000 | -29.3% | 274,074 | +7.0% | 0.65% | -39.1% |
| Q3 2017 | $3,771,000 | +28.7% | 256,215 | +40.7% | 1.06% | -1.8% |
| Q2 2017 | $2,931,000 | +1.0% | 182,141 | 0.0% | 1.08% | -36.7% |
| Q1 2017 | $2,902,000 | +31.0% | 182,141 | 0.0% | 1.71% | -6.4% |
| Q4 2016 | $2,215,000 | +219.2% | 182,141 | +264.3% | 1.83% | +225.4% |
| Q3 2016 | $694,000 | -23.6% | 50,000 | 0.0% | 0.56% | -37.8% |
| Q2 2016 | $908,000 | – | 50,000 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |